Spinal Surgery

Latest Issue of OR Manager
November 2024
Home Surgery/Specialties > Spinal Surgery

Outpatient vs inpatient anterior cervical discectomy, fusion

Editor's Note Anterior cervical discectomy and fusion (ACDF) can be performed on an outpatient basis with comparable morbidity, readmission rates, and lower costs as on an inpatient basis, finds this study. In this analysis of 3,135 outpatient and 46,966 inpatient ACDFs, the mean Charlson comorbidity index, length of stay, and…

Read More

By: Judy Mathias
April 4, 2018
Share

Spinal fusion devices poised for growth

Editor's Note Transparency Market Research predicts the global spinal fusion devices market will reach more than $10.97 billion by 2025, with a compound annual growth rate of 4.65%, the March 19 Becker’s Spine Review reports. Growth will be driven by the aging US population that is susceptible to degenerative spine…

Read More

By: Judy Mathias
March 21, 2018
Share

Model helps predict pain, functional outcomes after lumbar spine surgery

Editor's Note In this study, researchers used patient-reported outcome (PRO) scores from 15 hospitals in Washington to create a clinical prediction model for spine surgery patients that explains most of the variability in pain reduction and functional improvement after surgery. The researchers found that after lumbar fusion surgery: 58.0% had…

Read More

By: Judy Mathias
March 7, 2018
Share

Analysis predicts growth for thoracolumbar spine devices market

Editor's Note A Technavio analysis predicts that the global market for thoracolumbar spine devices will see a compound annual growth rate of almost 4% through 2022, the March 1 Becker’s SpineReview reports. A major driver of the growth is the increasing prevalence of spinal disorders. The market was dominated in…

Read More

By: Judy Mathias
March 7, 2018
Share

Sponsored Message

Growth predicted for minimally invasive spine surgery market

Editor's Note A Healthcare Market Reports analysis predicts the minimally invasive spine surgery market will see a compound annual growth rate of 7.57% through 2020, the January 4 Becker’s Spine Review reports. The increasing incidence of spinal disorders is boosting the market, and a key market trend is the minimally…

Read More

By: Judy Mathias
January 8, 2018
Share

Research report predicts growth for arthroscopic devices market

Editor's Note A Persistence Market Research report predicts the global arthroscopic devices market will exceed $1.7 billion by 2022, with a 5.1% compound annual growth rate, according to the January 3 Becker’s Spine Review. A rising demand for minimally invasive procedures and an increasing geriatric population are the main contributors…

Read More

By: Judy Mathias
January 5, 2018
Share

Sponsored Message

RTI Surgical announces 3D-printed cervical interbody device

Editor's Note RTI Surgical (Alachua, Florida) on October 25 launched its Fortilink-C interbody fusion system with Tetrafuse 3D technology, the October 26 Becker’s Spine Review reports. Tetrafuse 3D technology combines titanium, allograft bone, and PEEK all in one device. The 3D-printed, polymer-based, cervical interbody device incorporates micro, macro, and nano-rough…

Read More

By: Judy Mathias
October 30, 2017
Share

Lumbar spine fusion market set for growth

Editor's Note Analysis by 360 Market Updates estimates that the lumbar spine fusion market will see a compound annual growth rate of 4.9% through 2021, the September 15 Becker’s Spine Review reports. A key driver of growth is the increasing popularity of physician-owned ambulatory surgery centers. DePuy Synthes, Medtronic, Stryker,…

Read More

By: Judy Mathias
September 18, 2017
Share

Report predicts growth of spinal implant market

Editor's Note A Market Research Future report predicts the global market for spinal implants will reach $14 billion by 2011 because of an increasing prevalence of spinal injuries and disorders and an aging population, according to the July 5 Becker’s Spine Review. The costliness of spinal implants and unfavorable reimbursement…

Read More

By: Judy Mathias
July 6, 2017
Share

FDA: Class I recall of Zimmer Biomet implantable spinal fusion stimulators

Editor's Note The Food and Drug Administration (FDA) on May 30 identified the recall by Zimmer Biomet (Warsaw, Indiana) of its SpF PLUS-Mini and SpF XL IIB implantable spinal fusion stimulators as Class I, the most serious. The recall was initiated because of higher than allowed levels of potential harmful…

Read More

By: Judy Mathias
May 31, 2017
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat